Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
Ali Alsugair,
Saubia Fathima,
Fnu Aperna,
Naseema Gangat,
Ayalew Tefferi
Affiliations
Ali Alsugair
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Saubia Fathima
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Fnu Aperna
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Naseema Gangat
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Ayalew Tefferi
Division of Hematology, Mayo Clinic, Rochester, Minnesota
